TeleMAb Retrospective Cohort Study

A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion

The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.

This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.

Inclusion Criteria:

• Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
• Gestational age <70 days (based on best obstetrical dating)
• English or Spanish speaking

Exclusion Criteria:

• Received mifepristone and misoprostol for early pregnancy loss
• Patient determined to have contraindication to medication abortion
• Opted for procedural management instead of medication abortion
• Decided to continue with the pregnancy
• Presenting for a second medication abortion at CUIMC during the study period
• Non-English or Spanish speaking